PARP1 c.93C>A ;(p.D31E)

Variant ID: 1-226595538-G-T

NM_001618.3(PARP1):c.93C>A;(p.D31E)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Ji, Jennifer X JX; Cochrane, Dawn R DR; Tessier-Cloutier, Basile B; Chen, Shary Yutin SY; Ho, Germain G; Pathak, Khyatiben V KV; Alcazar, Isabel N IN; Farnell, David D; Leung, Samuel S; Cheng, Angela A; Chow, Christine C; Colborne, Shane S; Negri, Gian Luca GL; Kommoss, Friedrich F; Karnezis, Anthony A; Morin, Gregg B GB; McAlpine, Jessica N JN; Gilks, C Blake CB; Weissman, Bernard E BE; Trent, Jeffrey M JM; Hoang, Lynn L; Pirrotte, Patrick P; Wang, Yemin Y; Huntsman, David G DG
Publication Date: 2020-08-15

Variant appearance in text: PARP: D31E
PubMed Link: 32409304
Variant Present in the following documents:
  • Main text
View BVdb publication page